[What determines corticosteroid choice in a specific patient?].
García Sánchez
Valle
V
Unidad Clínica de Aparato Digestivo, Hospital Universitario Reina Sofía, Córdoba, España. vallegarciasanchez@gmail.com
Iglesias Flores
Eva
E
Gómez Camacho
Federico
F
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001847:Bone Diseases / Q000139:chemically induced; D019819:Budesonide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D019090:Case Management; D002648:Child; D018849:Controlled Clinical Trials as Topic / Q000706:statistics & numerical data; D003424:Crohn Disease / Q000188:drug therapy; D003692:Delayed-Action Preparations; D004198:Disease Susceptibility; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007239:Infections / Q000209:etiology; D015201:Meta-Analysis as Topic; D009135:Muscular Diseases / Q000139:chemically induced; D010913:Pituitary-Adrenal System / Q000187:drug effects; D017410:Practice Guidelines as Topic; D012074:Remission Induction
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D019819:Budesonide